In brief
The U.S. Department of Health and Human Services (HHS) has unveiled a new artificial intelligence strategy aimed at improving efficiency and innovation across the department. While the plan promises benefits in healthcare analytics and drug development, experts express concerns about the protection of sensitive health information. HHS's approach emphasizes a 'try-first' culture and highlights the ambitious goal of increasing AI implementations by 70% in the next year.
NEW YORK (RTW News) — On Thursday, the U.S. Department of Health and Human Services (HHS) announced a new strategy focused on integrating artificial intelligence (AI) into its workflows, building on previous administrations' efforts. The outlined plan is aimed at making the agency's work more efficient and encourages AI adoption across various divisions. HHS described the strategy as a 'first step' towards promoting innovation, especially in patient data analysis and drug development.
Deputy HHS Secretary Jim O’Neill emphasized the need to overcome bureaucratic hurdles: For too long, our Department has been bogged down by bureaucracy and busy-work. It is time to tear down these barriers to progress and unite in our use of technology to Make America Healthy Again.
This new strategy aligns with a broader governmental embrace of AI, facilitating the use of advanced technology across the federal workforce. Previously, President Biden initiated an executive order to establish safeguards, but under President Trump, a challenging strategy to minimize AI's regulatory barriers was implemented.
Experts have voiced concerns regarding the potential risks associated with HHS’s plan, particularly its handling of sensitive health data. Oren Etzioni, AI expert, highlighted the importance of maintaining safety standards amid ambitious goals for centralized data and rapid AI deployment.
HHS's strategy indicates five key pillars for implementation, including the establishment of a governance structure to manage risks, empowering staff with AI tools, funding programs to develop standards for research, and integrating AI into public health operations. Yet some members of the community worry about the implications of AI analysis on personal health information, questioning if adequate protections are in place.
Despite the optimistic outlook for improved agency efficiency, critics assert the need for careful consideration of privacy issues, emphasizing that the tools' success should not compromise the confidentiality of personal health data.
The Department foresees a 70% increase in active AI implementations for the next financial year, inviting both hope and scrutiny from various stakeholders in the healthcare sector.
